We employ advanced techniques to gain comprehensive insights into the molecular mechanisms underlying aging processes. We are committed to accelerating progress in the field of aging-related diseases, striving to advance the discovery of treatments and therapeutics for a wide spectrum of conditions such as Alzheimer’s disease, osteoporosis, arthritis, Parkinson’s disease, cardiovascular diseases, and aging-related macular degeneration.
Omics technologies provide valuable tools to study aging at the molecular level. We can provide genomic, transcriptomic, proteomic, and metabolomic approaches that allow the integration of different types of aging data and drive further development of research in this field.
We are a contract research organization focused on aging research, specializing in providing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products.
Learn more：Aging Mechanisms
